Conversely, SMN immuno-gold particles were scarcely and randomly placed within NMJ from SMA mice compared with WT (Fig. 7), as expected by this double transgenic mouse model of SMA III, in which SMN protein levels are barely detectable compared with the homozygous strain. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.